M D Gupte

Summary

Country: India

Publications

  1. ncbi A study of antifungal antibiotic production by Streptomyces chattanoogensis MTCC 3423 using full factorial design
    M D Gupte
    Food and Fermentation Technology Division, University of Mumbai, Department of Chemical Technology, Matunga, Mumbai, India
    Lett Appl Microbiol 35:22-6. 2002
  2. ncbi Components of small area variation in fertility rates among married women in south India
    B N Murthy
    National Institute of Epidemiology Indian Council of Medical Research, Chennai 600 031, India
    Int J Epidemiol 32:639-44. 2003
  3. ncbi Lot quality assurance sampling (LQAS) for monitoring leprosy elimination in an endemic district in Tamilnadu
    B N Murthy
    National Institute of Epidemiology, Mayor V.R. Ramanathan Road, Chetpet, Chennai 600 031
    Indian J Lepr 73:111-9. 2001
  4. ncbi Prevalence and distribution of cardiovascular risk factors in an urban industrial population in south India: a cross-sectional study
    P Kaur
    National Institute of Epidemiology, Indian Council of Medical Research, Plot R 127, 3rd Avenue, Ambattur Housing Board, Phase I and II, Chennai, India
    J Assoc Physicians India 55:771-6. 2007
  5. ncbi Perception of HIV testing among attendees at an STD clinic in India
    T Subramanian
    ICMR, National Institute of Epidemiology, Chennai, India
    AIDS Care 20:26-34. 2008
  6. ncbi HIV-1 prevalence in young adults in south India
    M D Gupte
    Lancet 368:114; author reply 115-6. 2006
  7. ncbi Estimation of measles vaccination coverage using the Lot Quality Assurance Sampling (LQAS) method--Tamilnadu, India, 2002-2003
    Saravanan Sivasankaran
    National Institute of Epidemiology, Chennai, India
    MMWR Morb Mortal Wkly Rep 55:16-9. 2006
  8. ncbi A clinical trial in a developing country: many questions, few answers
    Somboon Kietinun
    Faculty of Medicine, Thammasat University, Klong Loung, Pathumatani, Thailand
    Issues Med Ethics 11:89-90. 2003
  9. ncbi Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India
    Sudhir Sinha
    CJIL, Agra, Presently Division of Biochemistry, Central Drug Research Institute (CSIR, Lucknow, India
    Lepr Rev 75:266-73. 2004
  10. ncbi An institutional outbreak of leptospirosis in Chennai, South India
    R Ramakrishnan
    National Institute of Epidemiology (ICMR, Chennai
    J Commun Dis 35:1-8. 2003

Collaborators

  • B N Murthy
  • R Ramakrishnan
  • Sanjay M Mehendale
  • T Subramanian
  • Axel Kroger
  • P Manickam
  • P Kaur
  • Saravanan Sivasankaran
  • Sudhir Sinha
  • Somboon Kietinun
  • P V Asha Bai
  • V Pannikar
  • K Ramalingam
  • Vitthal Jadhav
  • V S Dorairaj
  • K Katoch
  • A K Mathai
  • Shen Jianping
  • P Krishnamurthy
  • K Boopathi
  • M T Htoon
  • A Jamesh
  • A M Narayanan
  • T V Rao
  • R Ezhil
  • S Sankarasubbaiyan
  • Sudha Ramachandra Rao
  • Y Hutin
  • B Nagaraju
  • S Kannan
  • U Sengupta
  • Amit Sengupta
  • M Chellamariappan
  • C V Krishnaswami

Detail Information

Publications13

  1. ncbi A study of antifungal antibiotic production by Streptomyces chattanoogensis MTCC 3423 using full factorial design
    M D Gupte
    Food and Fermentation Technology Division, University of Mumbai, Department of Chemical Technology, Matunga, Mumbai, India
    Lett Appl Microbiol 35:22-6. 2002
    ..To determine the correct levels of the three process parameters identified as the most important for maximum production of antifungal antibiotic by the newly isolated strain of Streptomyces chattanoogensis MTCC 3423...
  2. ncbi Components of small area variation in fertility rates among married women in south India
    B N Murthy
    National Institute of Epidemiology Indian Council of Medical Research, Chennai 600 031, India
    Int J Epidemiol 32:639-44. 2003
    ..To adapt and develop a method for finding out what proportion of the variation among small areas in the number of births to married women is excess (systematic) variation over and above the chance (random) variation...
  3. ncbi Lot quality assurance sampling (LQAS) for monitoring leprosy elimination in an endemic district in Tamilnadu
    B N Murthy
    National Institute of Epidemiology, Mayor V.R. Ramanathan Road, Chetpet, Chennai 600 031
    Indian J Lepr 73:111-9. 2001
    ..LQAS may be used as a tool by which one can identify high prevalence districts and target them for necessary strengthening of the programme. It may also be considered for certifying elimination achievement for a given area...
  4. ncbi Prevalence and distribution of cardiovascular risk factors in an urban industrial population in south India: a cross-sectional study
    P Kaur
    National Institute of Epidemiology, Indian Council of Medical Research, Plot R 127, 3rd Avenue, Ambattur Housing Board, Phase I and II, Chennai, India
    J Assoc Physicians India 55:771-6. 2007
    ..This study was done to determine the prevalence of cardiovascular risk factors in two industrial units in Chennai, India...
  5. ncbi Perception of HIV testing among attendees at an STD clinic in India
    T Subramanian
    ICMR, National Institute of Epidemiology, Chennai, India
    AIDS Care 20:26-34. 2008
    ..001). The findings in this study will help optimize HIV testing in at risk patient populations in India...
  6. ncbi HIV-1 prevalence in young adults in south India
    M D Gupte
    Lancet 368:114; author reply 115-6. 2006
  7. ncbi Estimation of measles vaccination coverage using the Lot Quality Assurance Sampling (LQAS) method--Tamilnadu, India, 2002-2003
    Saravanan Sivasankaran
    National Institute of Epidemiology, Chennai, India
    MMWR Morb Mortal Wkly Rep 55:16-9. 2006
    ..Monthly review of vaccination coverage by subcenter and village is recommended to identify pockets of unvaccinated children and to maintain uniform high coverage in the PPHC area...
  8. ncbi A clinical trial in a developing country: many questions, few answers
    Somboon Kietinun
    Faculty of Medicine, Thammasat University, Klong Loung, Pathumatani, Thailand
    Issues Med Ethics 11:89-90. 2003
  9. ncbi Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India
    Sudhir Sinha
    CJIL, Agra, Presently Division of Biochemistry, Central Drug Research Institute (CSIR, Lucknow, India
    Lepr Rev 75:266-73. 2004
    ..The study clearly indicates that specific serological assays are not sensitive enough for application, both for diagnosis and for identifying any individual at risk for leprosy in the south Indian endemic population...
  10. ncbi An institutional outbreak of leptospirosis in Chennai, South India
    R Ramakrishnan
    National Institute of Epidemiology (ICMR, Chennai
    J Commun Dis 35:1-8. 2003
    ..No further cases occurred twelve days after implementing control measures. Access to clean water, not only for drinking but also for bathing, brushing and washing is essential to prevent water-borne outbreaks...
  11. ncbi Application of lot quality assurance sampling for leprosy elimination monitoring--examination of some critical factors
    M D Gupte
    National Institute of Epidemiology, Mayor VR Ramanathan Road, Chetpet, Chennai 600 031, Tamil Nadu, India
    Int J Epidemiol 33:344-8. 2004
    ..The present exercise was aimed at validating applicability of LQAS, and adopting these modifications for monitoring leprosy elimination in Tamil Nadu state, which was highly endemic for leprosy...
  12. ncbi Prevalence of known diabetes in Chennai City
    P V Asha Bai
    National Institute of Epidemiology, Chetpet, Chennai, India
    J Assoc Physicians India 49:974-81. 2001
    ..The causes for high prevalence in > or = 40 year age group needs to be explored in this population...
  13. ncbi International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results
    Axel Kroger
    UNICEF UNDP World Bank WHO Special Programme for Research and Training in Tropical Diseases TDR, WHO, Switzerland
    Trop Med Int Health 13:594-602. 2008
    ..To describe the rationale, design and preliminary results of an open trial of 6 months uniform multi-drug therapy (U-MDT) for all types of leprosy patients assuming a cumulative relapse rate not exceeding 5% over 5 years of follow-up...